Spravato (Intranasal Ketamine Treatment)

We plan on offering Spravato® (intranasal esketamine) as part of our mental health treatment options in the future. Spravato® is an FDA-approved medication administered through a nasal spray in a controlled clinical environment. It is designed to work differently than traditional antidepressants, offering a fast-acting alternative for individuals struggling with severe or persistent symptoms.

This treatment is intended for adults diagnosed with treatment-resistant depression, meaning they haven’t found relief with standard antidepressant medications. Spravato® may also support individuals dealing with major depressive disorder accompanied by suicidal thoughts. Administered under medical supervision, this therapy provides a safe and structured setting for those seeking a new path toward mental wellness. Spravato may be covered by your insurance provider.